| Smart drugs “as common as coffee”: media hype about neuroenhancement BJ Partridge, SK Bell, JC Lucke, S Yeates, WD Hall PLoS one 6 (11), e28416, 2011 | 254 | 2011 |
| Addiction: Current criticism of the brain disease paradigm R Hammer, M Dingel, J Ostergren, B Partridge, J McCormick, BA Koenig AJOB neuroscience 4 (3), 27-32, 2013 | 147 | 2013 |
| Deflating the neuroenhancement bubble JC Lucke, S Bell, B Partridge, WD Hall AJOB neuroscience 2 (4), 38-43, 2011 | 106 | 2011 |
| Australian university students’ coping strategies and use of pharmaceutical stimulants as cognitive enhancers C Jensen, C Forlini, B Partridge, W Hall Frontiers in psychology 7, 277, 2016 | 97 | 2016 |
| Verbal abuse and physical assault in the emergency department: Rates of violence, perceptions of safety, and attitudes towards security B Partridge, J Affleck Australasian Emergency Nursing Journal 20 (3), 139-145, 2017 | 89 | 2017 |
| Why Don’t Smokers Want Help to Quit? A Qualitative Study of Smokers’ Attitudes towards Assisted vs. Unassisted Quitting K Morphett, B Partridge, C Gartner, A Carter, W Hall International Journal of Environmental Research and Public Health 12 (6 …, 2015 | 88 | 2015 |
| How is acceptance of the brain disease model of addiction related to Australians’ attitudes towards addicted individuals and treatments for addiction? C Meurk, A Carter, B Partridge, J Lucke, W Hall BMC psychiatry 14 (1), 1-10, 2014 | 85 | 2014 |
| A ustralian university students' attitudes towards the use of prescription stimulants as cognitive enhancers: Perceived patterns of use, efficacy and safety B Partridge, S Bell, J Lucke, W Hall Drug and alcohol review 32 (3), 295-302, 2013 | 85 | 2013 |
| Australian university students’ attitudes towards the acceptability and regulation of pharmaceuticals to improve academic performance S Bell, B Partridge, J Lucke, W Hall Neuroethics 6, 197-205, 2013 | 78 | 2013 |
| Ethical concerns in the community about technologies to extend human life span B Partridge, M Underwood, J Lucke, H Bartlett, W Hall The American Journal of Bioethics 9 (12), 68-76, 2009 | 62 | 2009 |
| Researchers’ perspectives on scientific and ethical issues with transcranial direct current stimulation: An international survey K Riggall, C Forlini, A Carter, W Hall, M Weier, B Partridge, M Meinzer Scientific reports 5 (1), 10618, 2015 | 58 | 2015 |
| Over-diagnosed and over-treated: a survey of Australian public attitudes towards the acceptability of drug treatment for depression and ADHD B Partridge, J Lucke, W Hall BMC psychiatry 14 (1), 1-9, 2014 | 57 | 2014 |
| Non-medical prescription stimulant use to improve academic performance among Australian university students: prevalence and correlates of use J Lucke, C Jensen, M Dunn, G Chan, C Forlini, S Kaye, B Partridge, ... BMC Public Health 18 (1), 1-7, 2018 | 53 | 2018 |
| Dazed and confused: sports medicine, conflicts of interest, and concussion management B Partridge Journal of bioethical inquiry 11, 65-74, 2014 | 52 | 2014 |
| Academic Doping or Viagra for the Brain JC Lucke, SK Bell, BJ Partridge, WD Hall EMBO reports 12 (3), 197-201, 2011 | 52 | 2011 |
| A comparison of attitudes toward cognitive enhancement and legalized doping in sport in a community sample of Australian adults B Partridge, J Lucke, W Hall AJOB Primary Research 3 (4), 81-86, 2012 | 45 | 2012 |
| Ethical, social, and personal implications of extended human lifespan identified by members of the public B Partridge, J Lucke, H Bartlett, W Hall Rejuvenation research 12 (5), 351-357, 2009 | 40 | 2009 |
| Towards a smart population: A public health framework for cognitive enhancement J Lucke, B Partridge Neuroethics 6, 419-427, 2013 | 38 | 2013 |
| Concussion in sport: Conceptual and ethical issues MJ McNamee, B Partridge, L Anderson Kinesiology Review 4 (2), 190-202, 2015 | 37 | 2015 |
| Public attitudes in A ustralia towards the claim that addiction is a (brain) disease C Meurk, B Partridge, A Carter, W Hall, K Morphett, J Lucke Drug and alcohol review 33 (3), 272-279, 2014 | 37 | 2014 |
